{"podcast":{"title":"Health News Today | 2 Min News | The Daily News Now!","slug":"health-news-today-2-min-news-the-daily-news-now-7685759","podcast_index_feed_id":7685759,"rss_url":"https://feeds.fastcast.ai/health-and-fitness-news-today-2-min-news-the-daily-news-now.xml","website_url":null,"image_url":"https://image.fastcast.ai/cover/01017222-be18-4060-a2b6-ae821dbc23fa.png","author":"The Daily News Now!","episode_count":65,"summary":"Hosted by Corey with the Story, Health and Fitness News Today delivers fast, focused daily updates on the stories shaping health, wellness, and performance—from fitness trends and nutrition to medical breakthroughs and lifestyle insights. Designed for quick, on-the-go listening, each episode brings you up to speed in minutes. Produced by AI for speed, consistency, and global scale, the show is part of The Daily News Now network—covering the topics that impact your everyday life and keeping you informed. Health and Fitness News Today is your daily snapshot of what’s happening in health and wellness. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-09-18T04:22:25.318567+00:00","page_url":"https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759"},"episode":{"title":"Radioligand Therapy: Targeted Cancer Treatment | Health and Fitness News","slug":"radioligand-therapy-targeted-cancer-treatment-health-and-fitness-news","published_at":"2026-09-09T00:36:54+00:00","page_url":"https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759/radioligand-therapy-targeted-cancer-treatment-health-and-fitness-news","show_page_url":"https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759","url":"https://sources.thednn.ai/c4994d66d640fbbc","audio_url":"https://api.fastcast.ai/audio/a60e269f-83b3-40b4-8ea9-1d8cd86898cd.mp3","summary":"Radioligand therapy is a groundbreaking cancer treatment that delivers radiation directly to tumors using radioactive isotopes like lutetium-177, targeting specific receptors on cancer cells for precision strikes. Unlike traditional external beam radiation, this internal approach minimizes damage to healthy tissue. Approved in the U.S. as Pluvicto for metastatic prostate cancer, it involves six IV infusions spaced six weeks apart—quick, manageable, and similar to other intravenous treatments. After infusion, patients must follow strict safety protocols: drink plenty of fluids, avoid close contact with kids and pregnant women, sleep separately for days to weeks depending on who’s around, and practice hygiene like flushing toilets twice and washing hands often. While it requires temporary lifestyle adjustments, this targeted therapy offers hope for patients—and when side effects arise, medical teams are ready to help. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/c4994d66d640fbbc","meta_description":"Radioligand therapy is a groundbreaking cancer treatment that delivers radiation directly to tumors using radioactive isotopes like lutetium-177, targetin…","key_points":[],"chapters":[],"topics":[],"duration_seconds":126,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/health-news-today-2-min-news-the-daily-news-now-7685759/episodes/radioligand-therapy-targeted-cancer-treatment-health-and-fitness-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759/radioligand-therapy-targeted-cancer-treatment-health-and-fitness-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}